HAIL MERRY ISSUES VOLUNTARY RECALL DUE TO LABELING ERROR
May 23, 2017 16:33 pm UTC| Business
Dallas, TX, May 23, 2017 -- Hail Merry, a plant-based snack food company, voluntarily recalls its Meyer Lemon Mini Miracle Tarts Party Pack of 6 from the market due to a labeling error. The products contain cashews as...
DEINOVE WELCOMES ITS NEW DIRECTOR OF R&D, GEORGES GAUDRIAULT, PhD
May 23, 2017 16:32 pm UTC| Business
PhD in molecular pharmacology, expert in the development of new molecules and their formulation, Dr. Gaudriault has spent his entire career in pharmaceutical innovation. He will be a key player in DEINOVE's development in...
Air Industries Group Announces 2nd Closing of Bridge Loan and Delay in Filing of Form 10-Q
May 23, 2017 16:30 pm UTC| Business
HAUPPAUGE, N.Y., May 23, 2017 -- Air Industries Group (NYSE MKT:AIRI)(“Air Industries” or the “Company”), an integrated manufacturer of precision equipment assemblies and components for leading aerospace and defense...
May 23, 2017 16:28 pm UTC| Business
SANTA CLARA, Calif., May 23, 2017 -- Ooyala, a global provider of video monetization technology and services, filed a lawsuit today against Brightcove Inc. In the lawsuit, Ooyala details that the defendants engaged in...
Penns Woods Bancorp, Inc. Announces Quarterly Dividend
May 23, 2017 16:23 pm UTC| Business
WILLIAMSPORT, Pa., May 23, 2017 -- Richard A. Grafmyre CFP®, President and Chief Executive Officer of Penns Woods Bancorp, Inc., (NASDAQ:PWOD) has announced that the Company’s Board of Directors declared a second...
RUBY TO SPEAK ON DELIVERING DELIGHT AT TWILIO’S SIGNAL DEVELOPER CONFERENCE
May 23, 2017 16:19 pm UTC| Business
Portland, Oregon, May 23, 2017 -- Katharine Nester, Chief Product Technology Officer and Steve Severance, VP of Engineering at Ruby Receptionists, will speak at Twilio’s 2017 SIGNAL Developer Conference, Thursday,...
Onxeo Announces 10th Positive DSMB Recommendation to Continue Livatag® ReLive Phase III Trial in HCC
May 23, 2017 16:00 pm UTC| Business
PARIS, May 23, 2017 -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in...